Anatoli S Gleiberman

4PUBLICATIONS
34CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 02, 2025
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.

Ruby Pandher, Chengyuan Xue, Laura D Gamble

|Oct 23, 2023
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.

Alexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova

|Nov 30, 2022
Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors.

Ksenia A Novototskaya-Vlasova, Nickolay S Neznanov, Ivan Molodtsov

|May 27, 2021
Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53.

Natalia Fedtsova, Elena A Komarova, Kellee F Greene

Pageof 1